Bonus Biogroup Revenue

Biotechnology Research • Haifa, Haifa District, Israel • 21-50 Employees

Bonus Biogroup revenue & valuation

Annual revenue	$3,593,310
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,500,000
Total funding	No funding

Key Contact at Bonus Biogroup

Shai Meretzki

Founder, Ceo & President

Company overview

Headquarters	8 Nahum Hat (נחום חת), P.O.B 15143, Haifa, Matam Advanced Technology Park 31905 , IL
Phone number	+972732067104
Website	bonus-bio.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Mesenchymal Stem Cells, Orthopedics, Innovation, Biomedical Engineering, Bone Tissue Engineering, Adipose-Derived Stem Cells, Critical Gap Bone Fractures, Maxillofacial Tissue Engineering
Employees	21-50
Socials

Bonus Biogroup Email Formats

Bonus Biogroup uses 2 email formats. The most common is {first initial} (e.g., j@bonus-bio.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@bonus-bio.com	50%
{first initial}_{last name}	j_doe@bonus-bio.com	50%

About Bonus Biogroup

Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company engaged in the R&D of tissue-engineered and cell therapy products. Bonus CEO Dr. Shai Meretzki, one of Israel's most prominent biotech entrepreneurs, founded Bonus to build live tissues outside the body. He started with bones, developing BonoFill, the world's first tissue-engineered viable bone graft for treating severe bone defects currently under-treated by transplanting bone from another part of the body with considerable limitations. The active ingredients in BonoFill are mesenchymal cells isolated from the patient's adipose tissue. Using BonoFill, bones were successfully regenerated in already dozens of patients that recovered from years of disabilities. During the coronavirus outbreak, Bonus started developing MesenCure based on mesenchymal cells to treat life-threatening pneumonia and cytokine storm in severe Covid-19 patients. With excellent clinical results and established manufacturing capacity, Bonus strives to continue saving and improving patients' lives and becoming a world leader in regenerative medicine.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Bonus Biogroup has 27 employees across 9 departments.

Departments

Number of employees

Funding Data

Bonus Biogroup has never raised funding before.

Bonus Biogroup Tech Stack

Discover the technologies and tools that power Bonus Biogroup's digital infrastructure, from frameworks to analytics platforms.

Joomla

CMS

jQuery UI

JavaScript libraries

Hotjar

Analytics

Animate.css

UI frameworks

Leaflet

Maps

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Ads

Advertising

jQuery

JavaScript libraries

LiteSpeed

Web servers

Google Ads

Advertising

HTTP/3

Miscellaneous

Frequently asked questions

Bonus Biogroup is located in Haifa, Haifa District, IL.

You can reach Bonus Biogroup at +972732067104.

Bonus Biogroup generates an estimated annual revenue of $3,593,310. This revenue figure reflects the company's market position and business performance in its industry.

Bonus Biogroup has an estimated valuation of $11,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Bonus Biogroup has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Bonus Biogroup

Shai Meretzki

Founder, Ceo & President

4.8

40,000 users